Summary
- Current Price
- As of today, GSK price is $52.88, up +3.38% on
- Current Price All-Time High
- GSK price is currently -31.36% below its historical high of $77.04 set on an earlier date
- Market Cap
- GSK current market cap is $106B, up +32.10% over the past 365 days
- PE Ratio
- GSK current PE ratio is 16.66
- Revenue
- GSK current annual revenue is $43.05B, up +7.38% year-over-year
- Next Earnings
- The next earnings release for GSK is on
Profile
| Metric | Value |
|---|---|
| Full Name | GSK plc |
| Ticker | NYSE: GSK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | gsk.com |
| Employees | 68,629 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $52.88 | |
| Price, 1D Change | +3.38% | |
| Market Cap | $106B | |
| TTM Dividend Yield | 3.46% | |
| PE Ratio | 16.66 | |
| Beta | 0.25 | |
| Revenue | $43.05B | |
| Revenue, 1Y Change | +7.38% | |
| EPS | $3.66 | |
| EPS, 1Y Change | +130.33% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.45 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 4:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GSK.V | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $3.66 | |
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| Revenue | $43.05B | |
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $52.88 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $2.98 | - | |
| - | $1.59 | - | |
| - | $3.66 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $37.70B | - | |
| - | $40.09B | - | |
| - | $43.05B | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +33.47% | |
| Price, 3Y | +53.41% | |
| Market Cap, 1Y | +32.10% | |
| Market Cap, 3Y | +51.62% | |
| Revenue, 1Y | +7.38% | |
| Revenue, 3Y | +19.19% | |
| EPS, 1Y | +130.33% | |
| EPS, 3Y | -59.44% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $52.88 | |
| SMA 200 | $52.06 | |
| SMA 50 | $51.83 | |
| EMA 200 | $50.59 | |
| EMA 50 | $51.74 | |
| MACD | -$0.19 | |
| Beta | 0.25 | |
| ATR | $1.21 | |
| 14-Day RSI | 57.04 | |
| 10-Day Volatility | 30.62% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.45 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.23% | |
| Total Dividend | $1.71 | |
| Dividends Paid | $3.38B | |
| Payout Ratio | 40.77% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $43.05B | |
| EPS | $3.66 | |
| Gross Profit | $30.76B | |
| Gross Margin | 71.46% | |
| Operating Income | $9.45B | |
| Operating Margin | 21.95% | |
| Net Income | $8.29B | |
| Net Margin | 19.25% | |
| EBITDA | $14.43B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 1.08 | |
| Current Ratio | 0.82 | |
| Quick Ratio | 0.54 | |
| Interest Coverage | - | |
| Piotroski F-Score | 8 | |
| Altman Z-Score | 1.73 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $22.03B | |
| Cash & Equivalents | $4.58B | |
| Total Assets | $82.21B | |
| Current Assets | $23.55B | |
| Total Liabilities | $60.75B | |
| Current Liabilities | $28.77B | |
| Total Debt | $23.83B | |
| Short Term Debt | $4.05B | |
| Accounts Payable | $4.75B |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $35.52B | |
| Operating Expenses | $21.78B | |
| Cost Of Goods Sold | $12.29B | |
| SG&A | $1.24B | |
| D&A | $3.05B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.47B |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $9.62B | |
| CFI | -$5.90B | |
| CFF | -$3.96B | |
| Capex | $3.93B | |
| Free Cash Flow | $5.69B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Barclays | → | |
| Jefferies | → | |
| Guggenheim | → | |
| UBS | → | |
| Jefferies | → | |
| Goldman Sachs | ||
| Guggenheim | → | |
| Morgan Stanley | ||
| Jefferies | → | |
| DZ Bank | → |
Analyst sentiment
Institutional ownership
Screeners with GSK
FAQ
- What is the ticker symbol for GSK plc?
- The ticker symbol for GSK plc is NYSE:GSK
- Does GSK plc pay dividends?
- Yes, GSK plc pays dividends. The last payment was $0.45, with an ex-dividend date on August 14, 2026
- What sector is GSK plc in?
- GSK plc is in the Healthcare sector
- What industry is GSK plc in?
- GSK plc is in the General Drug Manufacturers industry
- What country is GSK plc based in?
- GSK plc is headquartered in United Kingdom
- When did GSK plc go public?
- GSK plc initial public offering (IPO) was on March 28, 1980
- Is GSK plc in the S&P 500?
- No, GSK plc is not included in the S&P 500 index
- Is GSK plc in the NASDAQ 100?
- No, GSK plc is not included in the NASDAQ 100 index
- Is GSK plc in the Dow Jones?
- No, GSK plc is not included in the Dow Jones index
- When was GSK plc last earnings report?
- GSK plc's most recent earnings report was on July 28, 2026
- When does GSK plc report earnings?
- The next expected earnings date for GSK plc is October 28, 2026
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk